Abstract
Pharmacological science is trying to establish the link between chemicals, targets, and disease-related phenotypes. A plethora of chemical proteomics and structural data have been generated, thanks to the target-based approach that has dominated drug discovery at the turn of the century. There is an invaluable source of information for in silico target profiling. Prediction is based on the principle of chemical similarity (similar drugs bind similar targets) or on first principles from the biophysics of molecular interactions. In the first case, compound comparison is made through ligand-based chemical similarity search or through classifier-based machine learning approach. The 3D techniques are based on 3D structural descriptors or energy-based scoring scheme to infer a binding affinity of a compound with its putative target. More recently, a new approach based on compound set metric has been proposed in which a query compound is compared with a whole of compounds associated with a target or a family of targets. This chapter reviews the different techniques of in silico target profiling and their main applications such as inference of unwanted targets, drug repurposing, or compound prioritization after phenotypic-based screening campaigns.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ng JT, Dekker C, Reardon P et al (2016) Lessons from ten years of crystallization experiments at the SGC. Acta Crystallogr D Struct Biol 72:224–235
Mulinari S (2014) The specificity triad: notions of disease and therapeutic specificity in biomedical reasoning. Philos Ethics Humanit Med 9:14–25
Milletti F, Vulpetti A (2010) Predicting polypharmacology by binding site similarity: from kinases to the protein universe. J Chem Inf Model 50(8):1418–1431
Fliri AF, Loging WT, Thadeio PF et al (2005) Biological spectra analysis: linking biological activity profiles to molecular structure. Proc Natl Acad Sci 102(2):261–266
Card A, Caldwell C, Min H et al (2009) High-throughput biochemical kinase selectivity assays: panel development and screening applications. J Biomol Screen 14(1):31–42
Miduturu CV, Deng X, Kwiatkowski N et al (2011) High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors. Chem Biol 18(7):868–879
Awale M, Reymond JL (2017) The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity data. J Cheminform 9(1):1–10
Li Q, Cheng T, Wang Y et al (2010) PubChem as a public resource for drug discovery. Drug Discov Today 15(23–24):1052–1057
Gaulton A, Hersey A, Nowotka ML et al (2017) The ChEMBL database in 2017. Nucleic Acids Res 45(D1):D945–D954
Liu X, Xu Y, Li S et al (2014) In silico target fishing: addressing a “Big Data” problem by ligand-based similarity rankings with data fusion. J Cheminform 6(1):1–14
Schmidt F, Matter H, Hessler G et al (2014) Predictive in silico off-target profiling in drug discovery. Future Med Chem 6(3):295–317
Gregori-puigjané E, Mestres JA (2008) Ligand-based approach to mining the chemogenomic space of drugs. Comb Chem High Throughput Screen 11:669–676
Mestres J, Martín-Couce L, Gregori-Puigjané E et al (2006) Ligand-based approach to in silico pharmacology: nuclear receptor profiling. J Chem Inf Model 46(6):2725–2736
Keiser MJ, Roth BL, Armbruster BN et al (2007) Relating protein pharmacology by ligand chemistry. Nat Biotechnol 25(2):197–206
Zhao Z, Xie L, Xie L et al (2016) Delineation of polypharmacology across the human structural kinome using a functional site interaction fingerprint approach. J Med Chem 59(9):5b02041
Brylinski M, Skolnick J (2010) Cross-reactivity virtual profiling of the human kinome by X-React KIN: a chemical systems biology approach. Mol Pharm 206(1):1–8
Hopkins A (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4(11):682–690
Tang J, Aittokallio T (2014) Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles. Curr Pharm Des 20(1):23–36
Anighoro A, Bajorath J, Rastelli G (2014) Polypharmacology: challenges and opportunities in drug discovery. J Med Chem 57(19):7874–7887
Phatak SS, Zhang S (2013) A novel multi-modal drug repurposing approach for identification of potent ACK1 inhibitors. Pac Symp Biocomput 2013:29–40
Sekhon BS (2013) Repositioning drugs and biologics: retargeting old/existing drugs for potential new therapeutic applications. J Pharm Educ Res 4:1–15
Dubus E, Ijjaali I, Barberan O et al (2009) Drug repositioning using in silico compound profiling. Future Med Chem 1(9):1723–1736
Corsello SM, Bittker JA, Liu Z et al (2017) The Drug Repurposing Hub: a next-generation drug library and information resource. Nat Med 23(4):405–408
Jenkins JL, Bender A, Davies JW (2006) In silico target fishing: predicting biological targets from chemical structure. Drug Discov Today Technol 3(4):413–421
Drakakis G, Wafford KA, Brewerton SC et al (2017) Polypharmacological in silico bioactivity profiling and experimental validation uncovers sedative-hypnotic effects of approved and experimental drugs in rat. ACS Chem Biol 12(6):1593–1602
Chaudhari R, Tan Z, Huang B et al (2017) Computational polypharmacology: a new paradigm for drug discovery. Expert Opin Drug Discov 12(3):279–291
Hu Y, Gupta-Ostermann D, Bajorath J (2014) Exploring compound promiscuity patterns and multi-target activity spaces. Comput Struct Biotechnol J 9:e201401003
Rogers D, Hahn M (2010) Extended-connectivity fingerprints. J Chem Inf Model 50:742–754
O’Boyle NM, Sayle RA (2016) Comparing structural fingerprints using a literature-based similarity benchmark. J Cheminform 8(1):1–14
Baldi P, Nasr R (2010) When is chemical similarity significant? The statistical distribution of chemical similarity scores and its extreme values. J Chem Inf Model 50(7):1205–1222
Nicola G, Liu T, Gilson MK (2012) Public domain databases for medicinal chemistry. J Med Chem 55(16):6987–7002
Taboureau O, Nielsen SK, Audouze K et al (2011) ChemProt: a disease chemical biology database. Nucleic Acids Res 39:D367–D372
Kringelum J, Kjaerulff SK, Brunak S et al (2016) ChemProt-3.0: a global chemical biology diseases mapping. Database 2016:1–7
Sheridan RP, Shpungin J (2004) Calculating similarities between biological activities in the MDL drug data report database. J Chem Inf Comput Sci 44(2):727–740
Mathias SL, Hines-Kay J, Yang JJ et al (2013) The CARLSBAD database: a confederated database of chemical bioactivities. Database 2013:1–8
Krejsa CM, Horvath D, Rogalski SL et al (2003) Predicting ADME properties and side effects: the BioPrint approach. Curr Opin Drug Discov Devel 6(4):470–480
Petitet F, Barberan O, Dubus E et al (2006) Development of an ADME and drug-drug interactions knowledge database for the acceleration of drug discovery and development. Expert Opin Drug Discov 1(7):737–751
Booth A (2006) “Brimful of STARLITE”: toward standards for reporting literature searches. J Med Libr Assoc 94(4):421–429, e205
Southan C, Boppana K, Jagarlapudi SA et al (2011) Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: ranking 1654 human protein targets by assayed compounds and molecular scaffolds. J Cheminform 3(1):14
Wishart DS, Knox C, Guo AC et al (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36(Suppl. 1):901–906
Szklarczyk D, Santos A, Von Mering C et al (2016) STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res 44(D1):D380–D384
Wang Z, Li J, Dang R, Liang L et al (2015) PhIN: a protein pharmacology interaction network database. CPT Pharmacometrics Syst Pharmacol 4(3):160–166
Koscielny G, An P, Carvalho-Silva D et al (2017) Open targets: a platform for therapeutic target identification and validation. Nucleic Acids Res 45(D1):D985–D994
Wang X, Shen Y, Wang S et al (2017) PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res 45(W1):W356–W360
Gong J, Cai C, Liu X et al (2013) ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method. Bioinformatics 29(14):1827–1829
Liu X, Gao Y, Peng J et al (2015) TarPred: a web application for predicting therapeutic and side effect targets of chemical compounds. Bioinformatics 31(12):2049–2051
Nickel J, Gohlke BO, Erehman J et al (2014) SuperPred: update on drug classification and target prediction. Nucleic Acids Res 42(W1):26–31
Nguyen DT, Mathias S, Bologa C et al (2017) Pharos: collating protein information to shed light on the druggable genome. Nucleic Acids Res 45(D1):D995–D1002
Liu X, Baarsma HA, Thiam CH et al (2016) Systematic identification of pharmacological targets from small-molecule phenotypic screens. Cell Chem Biol 23(10):1302–1313
Yue Q-X, Cao Z-W, Guan S-H et al (2008) Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol Cell Proteomics 7(5):949–961
Yamanishi Y, Kotera M, Moriya Y et al (2014) DINIES: drug-target interaction network inference engine based on supervised analysis. Nucleic Acids Res 42(W1):39–45
Sharman JL, Benson HE, Pawson AJ et al (2013) IUPHAR-DB: updated database content and new features. Nucleic Acids Res 41(D1):1083–1088
Günther S, Kuhn M, Dunkel M et al (2008) SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res 36:919–922
Shi SH, Cai YP, Cai XJ et al (2014) A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease. PLoS One 9(3):e89123
Garcia-Serna R, Ursu O, Oprea TI et al (2010) iPHACE: integrative navigation in pharmacological space. Bioinformatics 26(7):985–986
Garcia-Serna R, Mestres J (2010) Anticipating drug side effects by comparative pharmacology. Expert Opin Drug Metab Toxicol 6(10):1253–1263
Pogodin PV, Lagunin AA, Filimonov DA et al (2015) PASS Targets: ligand-based multi-target computational system based on a public data and naïve Bayes approach. SAR QSAR Environ Res 26(10):783–793
Reker D, Rodrigues T, Schneider P et al (2014) Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus. Proc Natl Acad Sci 111(11):4067–4072
Gfeller D, Grosdidier A, Wirth M et al (2014) SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res 42(W1):32–38
Wang L, Ma C, Wipf P et al (2013) TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database. AAPS J 15(2):395–406
Nigsch F, Bender A, Jenkins JL et al (2008) Ligand-target prediction using winnow and naive Bayesian algorithms and the implications of overall performance statistics. J Chem Inf Model 48(12):2313–2325
Asafu-Adjei JK, Betensky RA (2015) A pairwise Naïve Bayes approach to Bayesian classification. Intern J Pattern Recognit Artif Intell 29(7):1550023
Zhang Z (2016) Naïve Bayes classification in R. Ann Transl Med 4(12):241–246
Zhang J, Han B, Wei X et al (2012) A two-step target binding and selectivity support vector machines approach for virtual screening of dopamine receptor subtype-selective ligands. PLoS One 7(6):e39076
Balfer J, Heikamp K, Laufer S et al (2014) Modeling of compound profiling experiments using support vector machines. Chem Biol Drug Des 84(1):75–85
Heikamp K, Bajorath J (2014) Support vector machines for drug discovery. Expert Opin Drug Discov 9(1):93–104
Huang S, Nianguang CAI, Penzuti Pacheco P et al (2018) Applications of support vector machine (SVM) learning in cancer genomics. Cancer Genomics Proteomics 15(1):41–51
Cichonska A, Ravikumar B, Parri E et al (2017) Computational-experimental approach to drug-target interaction mapping: a case study on kinase inhibitors. PLoS Comput Biol 13(8):1–28
Li YH, Xu JY, Tao L et al (2016) SVM-prot 2016: a web-server for machine learning prediction of protein functional families from sequence irrespective of similarity. PLoS One 11(8):1–14
Keum J, Nam H (2017) SELF-BLM: prediction of drug-target interactions via self-training SVM. PLoS One 12(2):1–16
Ding P, Yan X, Liu Z et al (2018) PTS: a pharmaceutical target seeker. Database 2017 2017:bax095
Huang H, Zhang G, Zhou Y et al (2018) Reverse screening methods to search for the protein targets of chemopreventive compounds. Front Chem 6:138
Cotesta S, Giordanetto F, Trosset J-Y et al (2005) Virtual screening to enrich a compound collection with CDK2 inhibitors using docking, scoring, and composite scoring models. Proteins 60(4):629–643
Trosset J-Y, Dalvit C, Knapp S et al (2006) Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening. Proteins 64(1):60–67
Li GB, Yu ZJ, Liu S et al (2017) IFPTarget: a customized virtual target identification method based on protein-ligand interaction fingerprinting analyses. J Chem Inf Model 57(7):1640–1651
Trosset J-Y, Scheraga HA (1998) Reaching the global minimum in docking simulations: a Monte Carlo energy minimization approach using Bezier splines. Proc Natl Acad Sci U S A 95(14):8011–8015
Allen WJ, Balius TE, Mukherjee S et al (2015) DOCK 6: impact of new features and current docking performance. J Comput Chem 36(15):1132–1156
Li H, Gao Z, Kang L et al (2006) TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res 34:219–224
Chen B, Mcconnell KJ, Wale N et al (2011) Comparing bioassay response and similarity ensemble approaches to probing protein pharmacology. Bioinformatics 27(21):3044–3049
Yao ZJ, Dong J, Che YJ et al (2016) TargetNet: a web service for predicting potential drug–target interaction profiling via multi-target SAR models. J Comput Aided Mol Des 30(5):413–424
Lee K, Lee M, Kim D (2017) Utilizing random Forest QSAR models with optimized parameters for target identification and its application to target-fishing server. BMC Bioinformatics 18(Suppl 16):75–86
González-Medina M, Prieto-Martínez FD, Owen JR et al (2016) Consensus diversity plots: a global diversity analysis of chemical libraries. J Cheminform 8(1):1–11
Fernández-De Gortari E, García-Jacas CR, Martinez-Mayorga K et al (2017) Database fingerprint (DFP): an approach to represent molecular databases. J Cheminform 9(1):1–9
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Trosset, JY., Cavé, C. (2019). In Silico Drug–Target Profiling. In: Moll, J., Carotta, S. (eds) Target Identification and Validation in Drug Discovery. Methods in Molecular Biology, vol 1953. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9145-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9145-7_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9144-0
Online ISBN: 978-1-4939-9145-7
eBook Packages: Springer Protocols